Drugs@FDA: FDA-Approved Drugs
Biologic License Application (BLA): 021289
Company: FERRING
Company: FERRING
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| BRAVELLE | UROFOLLITROPIN | 75 IU/VIAL | INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS | Discontinued | None | No | No |
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
|---|---|---|---|---|---|
| 02/19/2014 | SUPPL-19 | Efficacy-Labeling Change With Clinical Data | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021289s019lbl.pdf | |
| 05/06/2002 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-289_Bravelle_prntlbl.pdf |